We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Lay healthcare worker financial toxicity intervention: a pilot financial toxicity screening and referral program

    Purpose

    Financial toxicity is a source of significant distress for patients with urologic cancers, yet few studies have addressed financial burden in...

    Divya A Parikh, Gladys M. Rodriguez, ... Manali I. Patel in Supportive Care in Cancer
    Article 16 February 2024
  2. Cardiovascular toxicity of checkpoint inhibitors: review of associated toxicity and design of the Spanish Immunotherapy Registry of Cardiovascular Toxicity

    Immune checkpoint inhibitors (ICI) have changed the prognosis of many tumors. However, concerning associated cardiotoxicity has been reported. Little...

    Eduardo Zatarain-Nicolás, Pilar Martín, ... Teresa López Fernández in Clinical and Translational Oncology
    Article 25 May 2023
  3. Financial Toxicity

    Despite universal health insurance and a well-established social security system in Germany, it is possible that cancer survivors will experience...

    Matthias Büttner in Forum
    Article 21 April 2023
  4. Toxicity in Older Patients with Cancer Receiving Immunotherapy: An Observational Study

    Background

    Checkpoint inhibition has emerged as an effective treatment strategy for a variety of cancers, including in older adults. However, older...

    Estelle Tran Van Hoi, Stella Trompet, ... Marloes Derks in Drugs & Aging
    Article Open access 10 May 2024
  5. Evolution of predictive risk factor analysis for chemotherapy-related toxicity

    The causes of variation in toxicity to the same treatment regimen among seemingly similar patients remain largely unknown. There was tremendous...

    Daniel L. Hertz, Maryam B Lustberg, Stephen Sonis in Supportive Care in Cancer
    Article 29 September 2023
  6. Reporting time toxicity in prospective cancer clinical trials: A sco** review

    Purpose

    This review aimed to assess the measurement and reporting of time toxicity (i.e., time spent receiving care) within prospective oncologic...

    Patrick L. Quinn, Shah Saiyed, ... Aslam Ejaz in Supportive Care in Cancer
    Article 08 April 2024
  7. Comprehensive geriatric assessment predicts radiation-induced acute toxicity in prostate cancer patients

    Purpose

    The purpose of the present prospective study was to evaluate the significance of geriatric conditions measured by a comprehensive geriatric...

    Katarzyna Paal, Bettina Stranz, ... Tanja Langsenlehner in Strahlentherapie und Onkologie
    Article Open access 02 September 2023
  8. Body composition measures as a determinant of Alpelisib related toxicity

    Background

    Body composition has emerged as an important prognostic factor in patients treated with cancer. Severe depletion of skeletal muscle,...

    Eliya Shachar, Ari Raphael, ... Shlomit Strulov Shachar in Breast Cancer Research and Treatment
    Article Open access 07 April 2024
  9. Characterizing Utilization and Outcomes of Digoxin Immune Fab for Digoxin Toxicity

    Background

    Digoxin is a widely prescribed drug for congestive heart failure and atrial fibrillation. Digoxin has a narrow therapeutic index and...

    Sophia Sheikh, Taylor Munson, ... Michael Ujhelyi in Drugs - Real World Outcomes
    Article Open access 05 June 2024
  10. Factors associated with early hydroxychloroquine-induced retinal toxicity in patients with systemic lupus erythematosus

    Purpose

    Hydroxychloroquine is currently recommended for the treatment of systemic lupus erythematosus (SLE), but it can cause irreversible retinal...

    Olga Araújo, Halbert Hernández-Negrín, ... Ricard Cervera in Graefe's Archive for Clinical and Experimental Ophthalmology
    Article 05 April 2024
  11. A prediction model for severe hematological toxicity of BTK inhibitors

    Bruton’s tyrosine kinase inhibitor (BTKi) has revolutionized the treatment of B-cell lymphomas. However, BTKi-related hematological toxicity hinders...

    Dan Jiang, Zaiwei Song, ... Rongsheng Zhao in Annals of Hematology
    Article 25 July 2023
  12. Characterization of time toxicity in older patients with metastatic breast cancer

    Purpose

    Recognizing that receiving healthcare can be time intensive and burdensome, time toxicity has been conceptualized as the time spent by...

    Swarali Y. Atre, Pamela R. Soulos, ... Maryam B. Lustberg in Breast Cancer Research and Treatment
    Article 31 May 2024
  13. Financial toxicity among cancer survivors: a conceptual model based on a feedback perspective

    Purpose

    Experiencing financial toxicity following a cancer diagnosis is a circular and complex process. We investigate the circular causal mechanisms...

    Alexander Scheidegger, Daniela Bernhardsgrütter, ... Eleonore Baum in Supportive Care in Cancer
    Article Open access 07 October 2023
  14. Using maximum plasma concentration (Cmax) to personalize taxane treatment and reduce toxicity

    Taxanes are a widely used class of anticancer agents that play a vital role in the treatment of a variety of cancers. However, toxicity remains a...

    Yuchen Sun, Yue Cheng, Daniel L. Hertz in Cancer Chemotherapy and Pharmacology
    Article 11 May 2024
  15. CAR-T Cell Therapy: the Efficacy and Toxicity Balance

    Purpose of Review

    Chimeric antigen receptor (CAR) T cell therapy is an immunotherapy that has resulted in tremendous progress in the treatment of...

    Karan L. Chohan, Elizabeth L. Siegler, Saad S. Kenderian in Current Hematologic Malignancy Reports
    Article 10 February 2023
  16. Pulmonary Toxicity Associated with Immune Checkpoint Inhibitors-Based Therapy: Current Perspectives and Future Directions

    Immune checkpoint inhibitors (ICIs) have shown efficacy in tumor therapy. However, the risk of pulmonary toxicity from ICI-based treatment regimens...

    Baohui Hong, Jiabing Zheng, ... **g Yang in Drug Safety
    Article 07 November 2023
  17. Ivabradine toxicity: a case report

    Background

    We describe a case of symptomatic bradycardia resulting from ivabradine toxicity by measurement of ivabradine levels, of which there are...

    Kavisha Singh, Muthukumar R. Alagarraju, ... Parag H. Joshi in Journal of Medical Case Reports
    Article Open access 24 October 2022
  18. Experiences of financial toxicity among caregivers of cancer patients: a meta-synthesis of qualitative studies

    Objectives

    The purpose of this study was to explore the experience of financial toxicity among caregivers of cancer patients and to provide...

    Yanan Shi, Ying Gao, ... Lijuan Yang in Supportive Care in Cancer
    Article 08 February 2024
  19. Toxicity of dose-escalated radiotherapy up to 84 Gy for prostate cancer

    Purpose

    The outcome of radiotherapy (RT) for prostate cancer (PCA) depends on the delivered dose. While the evidence for dose-escalated RT up to...

    Johannes Rosenbrock, Christian Baues, ... Simone Marnitz in Strahlentherapie und Onkologie
    Article Open access 17 March 2023
  20. Effectiveness and toxicity of five-fraction prone accelerated partial breast irradiation

    Purpose

    Our institution was an early adopter of 5-fraction accelerated partial breast irradiation (ABPI) to treat women with early-stage breast...

    Camille Hardy-Abeloos, Julie **ao, ... Naamit Gerber in Breast Cancer Research and Treatment
    Article 06 January 2024
Did you find what you were looking for? Share feedback.